Techindia Nirman Limited Announces Changes in Independent Directors
Techindia Nirman Limited announced the cessation of tenures for two independent directors, Mr. Vadla Nagabhushanam and Mr. Madhukar Dhondiraj Deshpande.Mr. Nagabhushanam’s term concluded on October 30, 2025. Mr. Deshpande's term ended on February 12, 2026.
The company expressed appreciation for the contributions of both directors during their tenures.
According to filings, Mr. Nagabhushanam held DIN 08863512, while Mr. Deshpande held DIN 07630081. Mr. Nagabhushanam was a member of the Audit Committee, Stakeholders Relationship Committee, and Nomination and Remuneration Committee, while Mr. Deshpande was a member of the Nomination and Remuneration Committee. Both directors ceased membership from their respective cessation dates.
The company noted a delay in the disclosure due to ongoing CIRP proceedings during the cessation period.
Table: Cessation of Independent Directors - Mr. Vadla Nagabhushanam
| Detail | Information |
|---|---|
| Name of Director | Mr. Vadla Nagabhushanam |
| DIN | 08863512 |
| Reason for Change | Completion of first term of appointment |
| Date of Cessation | October 30, 2025 |
| Directorship in other listed companies | Nath Bio-Genes (India) Limited |
Table: Cessation of Independent Directors - Mr. Madhukar Dhondiraj Deshpande
| Detail | Information |
|---|---|
| Name of Director | Mr. Madhukar Dhondiraj Deshpande |
| DIN | 07630081 |
| Reason for Change | Completion of first term of appointment |
| Date of Cessation | February 12, 2026 |
| Directorship in other listed companies | Nath Bio-Genes (India) Limited |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Last edited by a moderator: